Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Embolotherapy Market?
In the past few years, the embolotherapy market has seen impressive growth. From $4.44 billion in 2024, it is projected to expand to $4.86 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. This substantial growth in the historic period can be linked to the surging demand for embolotherapy for case treatment, a rise in cancer occurrences, an increase in peripheral vascular diseases, growing healthcare expenses, and heightened investments in research.
What Growth Rate Is Forecasted for the Embolotherapy Market by 2029?
In the coming years, the embolotherapy market is projected to experience robust growth. The market is forecasted to expand to a size of $6.83 billion in 2029, boasting a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this anticipated growth during the forecast period include an increase in disposable income, a heightened prevalence of chronic ailments, a rising interest in reproductive health, escalating numbers of chemoembolization procedures, and a growing incidence of liver cancer. Key trends to look out for during the forecast period include advanced technologies, both digital and analog devices, insertable cardiac monitors, embolotherapy methodologies, and strategic partnerships.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21181&type=smp
Which Key Companies Are Shaping the Future of the Embolotherapy Market?
Major companies operating in the embolotherapy market are Boston Scientific Corporation, Terumo Medical Corporation , Medtronic PLC, Johnson And Johnson, Stryker Corporation, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Shape Memory Medical Inc, Guerbet, IMBiotechnologies Ltd, Cardiva , Rapid Medical, Emboline Inc, Microport Scientific, Inari Medical, Instylla Inc, Embolx Inc, GE Healthcare, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE (SHENZHEN) CO., LTD, Achieva Medical Inc, Varian Medical Syatems Inc
Which Factors Are Driving Demand in the Embolotherapy Industry?
The embolotherapy market is anticipated to grow due to the increasing inclination towards minimally invasive procedures. These procedures, often cosmetic treatments, involve negligible surgical intervention, minimal recovery time, and lesser risks. The popularity of minimally invasive procedures is propelled by benefits such as rapid recovery, lessened pain, minimal scarring, fewer chances of complications, and advancements in technology. Embolotherapy boosts these procedures by selectively obstructing blood supply to targeted vessels, leading to decreased bleeding, effective tumor treatment, and precise management of vascular abnormalities with lesser complications. For example, in September 2023, the American Society of Plastic Surgeons, a non-profit organization based in the US, reported that cosmetic minimally invasive procedures saw a 7% growth in 2023, reaching 25,442,640, an increase from 23,672,269 in 2022. Therefore, the growth of the embolotherapy market is being fueled by the escalating preference for minimally invasive procedures.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21181&type=smp
How Is the Embolotherapy Market Segmented by Several Divisions?
The embolotherapy market covered in this report is segmented –
1) By Product: Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices
2) By Application: Oncology, Peripheral Vascular Diseases, Urology and Nephrology, Neurology, Gastrointestinal (GIT) Disorders
3) By Procedure: Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT), Transarterial Chemoembolization (TACE)
4) By End User: Ambulatory Surgical Centre, Hospitals And Clinics, Other End Users
Subsegments:
1) By Embolization Coil: Bare Coils, Coated Coils, Micro Coils
2) By Embolic Agents: Liquid Embolic Agents, Particulate Embolic Agents, Gelatin Sponge, Polyvinyl Alcohol (PVA) Particles
3) By Detachable Balloons: Single-Use Balloons, Multi-Use Balloons
4) By Embolic Plug Systems: Plug Kits, Distal Occlusion Systems
5) By Support Devices: Guidewires, Catheters, Sheath Introducers
What are the Emerging Market Trends Driving the Growth of the Embolotherapy Industry?
Companies that dominate the embolotherapy market are concentrating on the creation of innovative products like absorbable embolics systems, aiming to improve patient results and broaden treatment alternatives. Absorbable embolic systems are bioresorbable materials employed in embolization processes to obstruct blood supply to specific body tissues, such as tumor cells or aneurysms, which naturally diminishes within the body over a certain period. An example is Instylla Inc., a US-based medical equipment producer, who got U.S. Food and Drug Administration (FDA) 510(k) authorization in January 2025 for their Tembo embolic system. This device is a bioresorbable embolization agent composed of irregular dry-gelatin particles ranging from 85 to 255 µm. The system is engineered to embolize hypervascular tumors and occlude blood vessels in peripheral vascular systems. As per Instylla, Tembo has benefits like simple preparation, excellent visibility, and the capacity for dense packing of treated vessels, which may enhance existing permanent embolic solutions.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report
Which Regions Are Driving Growth in the Embolotherapy Market?
North America was the largest region in the embolotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the embolotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21181
This Report Delivers Insight On:
1. How big is the embolotherapy market, and how is it changing globally?
2. Who are the major companies in the embolotherapy market, and how are they performing?
3. What are the key opportunities and risks in the embolotherapy market right now?
4. Which products or customer segments are growing the most in the embolotherapy market?
5. What factors are helping or slowing down the growth of the embolotherapy market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model